Dr. Kampon Sriwatanakul
Degrees
1972 – Mahidol University – Medical Science – B.Sc
1974 – Mahidol University – Medicine (with Honor) – M.D.
1978 – Mahidol University – Pharmacology – Ph.D.
– Fellowship Training in Clinical Pharmacology, University of Rochester, New York, USA
– IU AC Fellowship Training in Chemotherapy, Royal Marsden Hospital, London, UK
– British Council Funded Research Fellow, University of Leicester, UK
– Fellowship Training in Clinical Pharmacokinetics, University of Edinburgh, UK
– Clinical Toxicology Training Course, University of Heidelberg, Germany
– Holistic Cancer Care Training, Aeskulap Klinik Hospital, Switzerland
Present Posts
1. Chairman of Thailand National Charter of Health
2. Holistic Wellness Group Leader, Thailand Wellness Association
3. Chairman of Thailand Wellness Tourism Network
4. Advisor, Mae Fah Luang University Hospital, Chiangrai
5. President of Reviva Medical Group
6. President of Stemcera Co.,Ltd. (Regenerative Rehabilitation Center @Piyavate Hospital)
7. President of Vitastem Global Network
8. President of Innopro Medical Group
9. President of Biosky Medical Group
10. Medical Director of Herb Treasure
11. Medical Director of LNG0168 Corporation
12. Founder and Chairman of Thailand Alternative Medicine Network (TAMN)
13. Advisor of the Thai Society of Anti-aging and Regenerative Medicine
14. Advisor, School of Anti-aging and Regenerative Medicine, Mae Fahluang University
15. Chairman of Stem Cell Transplantation Working Group, Bureau of Health Administration
Ministry of Public Health of Thailand
16. Founder and Secretary General of the Thai Society of Cellular Therapy
17. Advisor and President of several stem cell and biotechnology companies
18. Founder and President of several Anti-aging, Integrative, Holistic and Regenerative Medicine
Previous Posts
1. Intern, Ramathibodi Hospital : April 1974 – April 1975
2. Lecturer, Department of Pharmacology, Faculty of Science Mahidol
University : May 1975 – August 1979
3. Assistant Professor, Department of Pharmacology, Faculty of Science
Mahidol University : August 1979 – July 1985
4. Consultant to the Thai Food and Drug Administration, Ministry of Public Health.
5. Members of several subcommittees appointed by Ministry of Public
Health
6. Chairman, Department of Pharmacology, Faculty of Science, Mahidol University. : April 1984 –
March 1988
7. Director, Toxicology Graduate Program Faculty of Graduate Studies,
Mahidol University. : June 1984 – January 1989
8. Deputy Dean, Faculty of Graduate Studies, Mahidol University :
August 1988 – January 1989
9. Assistant to the President on Foreign Relations and Research
Mahidol University : February 1989 – April 1990
10. Vice President for Research and Foreign Relations, Mahidol University :
May 1990 – December 1991
11. Deputy Dean, Faculty of Graduate Studies, Mahidol University : January 1992 – April 1995
12. Founder and President of Stem Cell for Life Co.,Ltd.
13. Founder and President of Bio Eden Asia, Tooth Cell Banking
14. Medical Director of Health Baby Cord Blood Banking
Other Institution Posts
1. Member, The Medical Association of Thailand
2. Member, The Pharmacological and Therapeutic Society of Thailand
3. Member, The Toxicological Society of Thailand
4. Adjunct Scholar, Centre for the Study of Drug Development, Tufts University, Boston, USA.
5. Affiliated Physician, Aeskulap Hospital, Brunnen, Switzerland
6. Bioartificial Liver Project Co-ordinator, Cell Biotech Co., Ltd., Canada
7. Blood Substitute Project Co-ordinator, Dextrosang Co., Ltd., Canada
8. Medical Director of Complementary Cancer Care, McCormick Hospital
Academic and Research Awards
1. British Council Research Fellow in Pharmacology University of Leicester, Leicester, UK :
September 1978 – July 1979
2. Merck International Fellow in Clinical Pharmacology University of Rochester, Rochester, New
York, USA: January 1981 – December 1982
3. British Council Visiting Scientist Department of Clinical Pharmacology
University of Edinburgh, Edinburgh, UK : December 1987 – June 1988
4. UICC : Yamagiwa-Yoshisa Memorial International Cancer Study Grants
Institute of Cancer Research The Royal Marsden Hospital, Sutton, UK :
November 1988 – January 1989
5. Top 10 Innovation Business- Bio Eden Asia Co.,Ltd., The National Innovation Agency (NIA),
the Ministry of Science and Technology : December 2008
6. Innovation Ambassador, The National Innovation Agency (NIA), the Ministry of Science and
Technology : January 2009
7. International WHO’S WHO of Professionals, 2012
8. Chairman of Stem Cell Therapy Committee, Appointed by Ministry of Public Health, Thailand
9. Founding member of International Society of Stem Cell Regenerative Medicine, 2016
10. Organizing Committee, 10th Asia-Pacific Biotech Congress, 2016
11. AATSEA Outstanding Leadership Award in Community Development awarded by Association
of Agricultural Technology in Southeast Asia, November 2017
Current Research Interests
1. Clinical trials of new drugs
2. Clinical Pharmacokinetics
3. Development of Herbal Drugs
4. Obesity and metabolic syndrome
5. Anti-aging Medicine
6. Integrative Cancer Treatments
7. Stem Cell Technology
8. Complementary Medicine
9. Regenerative Medicine
10. Rehabilitation Medicine
Publications and Communications
1) Nahorski, SR and SRIWATANAKUL, K (1979) Analysis of the activity and distribution of beta-adrenoceptor antagonists using an ex vivo receptor binding assay. (Proceedings) Br. J. Pharmacol. 67: 415P
2) SRIWATANAKUL, K and Nahorski, SR (1980) Disposition and activity of beta-adrenoceptor antagonists using an ex-vivo receptor binding assy. Eur. J. Pharmacol. 66: 169-178 (Sriwatanakul and Nahorski 1980)*
3) SRIWATANAKUL, K and Preeyasombat, C (1981) Pitfalls in diagnosis of congenital hypothyroid. J. Medical Association of Thailand. 64:127-31
4) SRIWATANAKUL, K and Weintraub, M (1981) Analgesic use in the treatment of cancer pain. Thai Cancer J. 7: 111-116
5) SRIWATANAKUL, K (1981) Lowering of seizure threshold induced by phenothiazine therapy. Thai J. Pharmacol. 3: 95-100
6) Weis, O and SRIWATANAKUL, K (1982) Methotrimeprazine analgesia. Drug Therapy. 12: 143-147
7) SRIWATANAKUL, K and Weintraub, M (1982) Food-drug interaction: an overlooked clinical problem. Drug Therapy. 12: 157-159 (McCormick, Notar-Francesco, and Sriwatanakul 1983)*
8) SRIWATANAKUL, K (1982) Minimizing the risk of antipsychotic associated seizures. Drug Therapy. 12: 207-250
9) SRIWATANAKUL, K and Weis, O (1982) Using antipsychotic drugs in pregnancy. Drug Therapy. 12: 247-250 (Critchley et al. 1990)*
10) Weis, O, SRIWATANAKUL, K. and Weintraub, M (1982) ethotrimeprazine in acute porpyria. South African Med. J. 61: 985-986
11) Weis, O, SRIWATANAKUL, K and Weintraub, M (1982) Treatment of post-herpetic neuralgia and acute herpetic pain with amitryptyline and perphenazine. South African Med. J. 62: 274-275
12) Calimlim, JF, Wardell, WM, SRIWATANAKUL, K, Lasagna, L and Cox, C (1982) Analgesic efficacy of parenteral metkephamid acetate in the treatment of postoperative pain. Lancet 1: 1374-1375
13) SRIWATANAKUL, K, Kelvin, W and Lasagna, L (1982) The quantification of pain: an analysis of words used to describe pain and analgesia in clinical trials. Clin. Pharmacol Ther. 32: 143-148
14) SRIWATANAKUL, K (1982) A critical examination of drug interactions. Thai J. Pharmacol. 4: 17-35 (Wang and Sriwatanakul 1983)*
15) SRIWATANAKUL, K (1982) A critical examination of drug interactions. Thai J. Pharmacol. 4: 143-151 (Weis, Sriwatanakul, and Weintraub 1982)*
16) SRIWATANAKUL, K and Mehta, G (1983) Clinically significant drug interactions.
17) SRIWATANAKUL, K and Weintraub, M (1983) Understanding food-drug interactions. Comprehensive Therapy. 9: 6-11
18) Weis, OF, SRIWATANAKUL, K, Alloza, JL Weintraub, M and Lasagna, L (1983) Attitudes of patients, housestaff, and nurses towards postoperative analgesic care. Anesth. Anlgesia. 62: 70-74 (Sriwatanakul, Lasagna, and Cox 1983)*
19) Weis, OF, SRIWATANAKUL, K, and Alloza, JL (1983) Attitudes of patients, housestaff, and nurses towards postoperative analgesic care. Patient Education and Counseling 5: 96
20) Weis, OF, SRIWATANAKUL, K, Alloza, JL, Weintraub, M and Lasagna, L (1983) Attitudes of patients, housestaff, and nurses towards postoperative analgesic care. Survey of Anesthesiology 27: 240
21) Weis, OF, SRIWATANAKUL, K, Weintraub, M and Lasagna, L (1983) Reduction of anxiety and postoperative analgesic requirements by audiovisual instruction. Lancet 1: 43-44 (Jeenapongsa et al.
2003)*
22) Weintraub, M, SRIWATANAKUL, K, Sundaresan, PR, Weis, OF and Dorn, M (1983) Extended-release fenfluramine: patient acceptance and efficacy f evening dosing. Clin. Pharmacol. Ther. 33: 621-627
23) SRIWATANAKUL, K and Mehta, G (1983) Update review of clinically significant drug interactions. Drug Therapy. 13” 41-44
24) Wang, ZX and SRIWATANAKUL, K (1983) Drugs used for the treatment of dementia. Rational Drug Therapy.17: 1-4
25) SRIWATANAKUL, K, Kelvin, W, Lasagna, L, Calimlim, JF, Weis, OF and Mehta, G (1983) Studies with different types of visual analog scales for measurement of pain. Clin. Pharmacol. Ther. 34: 234-239
(K Sriwatanakul 1987)*
26) SRIWATANAKUL, K, lasagna, 1 and Cox, C (1983) Evaluation of current clinical trial methodology in analgesimetry based on experts opinions and analysis of several analgesic studies. Clin. Pharmacol.
Ther.34: 277-283 (K Sriwatanakul, Kelvie, and Lasagna 1982)*
27) SRIWATANAKUL, K (1983) Long-term follow-up of a clinical trial of anorexiant drugs. Thai J. Pharmacol. 5: 163-172
28) Makarananda, K and SRIWATANAKUL, K (1983) Cancer chemotherapy : Drug interaction. Thai Cancer J. 9: 55-59
29) SRIWATANAKUL, K (1983) Analysis of Narcotic Analgesic Usage in the Treatment of Postoperative Pain. JAMA J. American Medical Association. 250: 926
30) Weis, OF, SRIWATANAKUL, K, Alloza, JL, Kelvie, W, Weintraub, M and Lasagna, L (1983) Analysis of narcotic usage in the treatment of postoperative pain. JAMA J. American Medical Association. 250:
926-9
31) McCormick, K, Notar-Francesco, VJ and SRIWATANAKUL, K (1983) Inhibition by acetyl-CoA of hepatic carnitine acyltransferase and fatty acid oxidation. Biochemical Journal. 216: 499-502
32) Weis, OF, SRIWATANAKUL, K, Alloza, JL, Kelvie, W, Weintraub, M, Lasagna, L and Hunter, AR (1984) Analysis of Narcotic Analgesic Usage in the Treatment of Postoperative Pain. Survey of
Anesthesiology. 28: 236
33) Pothisiri, P, Makarananda, K, SRIWATANAKUL, K, Chroonroj, P, Pongprayoon, U and Eamungroj, S (1984) Prospective study of adverse reactions of antiepileptic drugs in Thai outpatients. Thai J. Pharmacol. 6: 1-10
34) Makarananda, K, SRIWATANAKUL, K, Pothsiri, P, Eamrungroj, S, Charoonroj, P and Pongprayoon, U (1985) Prospective study of adverse drug reactions of antihypertensive drugs in Thai outpatients. J. Med. Ass. Thailand. 68: 229-236
35) Yoovathawon, KC, SRIWATANAKUL, K and Thithapandha, A (1986) Influence of caffeine on aspirin pharmacokinetics. Eur. J.Drug Metab. Pharmacokinet. 11: 71-76
36) Unchern, S, Unchern, S, Chumsawat, P, SRIWATANAKUL, K and Limsuwan, A (1986) Psychomotor performances and subjective feeling studies with antihistamines. J. Med. Association. Thailand. 69: 203-209
37) SRIWATANAKUL, K and Pothisiri, P (1986) Adverse reaction assessment in Thailand. Med. Toxicol. 1(suppl 1): 105-109
38) SRIWATANAKUL, K and Osathakul, S (1986) Pycnodysostosis: a case report. J. Medical Association of Thailand. 2:12-6
39) Khanjanasthiti, P, Junnanond, C, Watthanakasert, S and SRIWATANAKUL, K (1987) Adolescent growth. J. Medical Association of Thailand. 70: 187-97
40) SRIWATANAKUL, K (1987) Need for chemicals safety information in Thailand. J. Toxicol. Sci. 12: 285-286 (Yanapirut and K Sriwatanakul 1987)*
41) Yanapirut, P and SRIWATANAKUL, K (1987) Prospective study of adverse reactions of anticancer drugs in Thai patients. J. Med. Association of Thailand. 70: 448-454
42) SRIWATANAKUL, K (1988) Mechanism of action of anorexiant agents-Amphetamine and other drugs.Medicographia. 10:22-23
43) Critchley, JA, Makarananda, K, Balali-Mood, M. SRIWATANAKUL, K and Lee, MR (1988) Further ethnic differences in the renal dopamine relationship : its uncoupling in the Iranian but not in Thai
normotensive subject. J. Hypertension 6(suppl 4): S623-S625 (K Sriwatanakul, McCormick, and Woolf 1984)*
44) Komindr, S, SRIWATANAKUL, K and Sriwatanakul, K (1988) Double-blind comparison study to determine the efficacy and safety of dexfenfluramine in the treatment of obese patients. Intern. Med. 4: 65-68
45) Critchley, JA, Makarananda, K, Balali-Mood, M. SRIWATANAKUL, K and Lee, MR (1989) Further ethnic differences in the renal sodium-dopamine relationship: its uncoupling in Iranian but not in Thai
normotensive subjects. J. Hypertension 6(suppl 4): S623-S625 (K Sriwatanakul, McCormick, and Woolf 1984)*
46) SRIWATANAKUL, K (1989) Trials of dipyrone in Thailand. Lancet. 1: 788 (K Sriwatanakul and Osathakul 1986)*
47) Critchley, JA, Lee, MR, Gordon, CJ, Makarananda, K, SRIWATANAKUL, K, Balali-Mood, M and Boye, GL (1989) Ethnic differences in the renal sodium-dopamine relationship : a possible explanation for regionai variation in the prevalence of hypertension? Eur. J. Clin. Pharmacol. 37: 559-562 (Weintraub
et al. 1983)*
48) Critchley, JA, SRIWATANAKUL, K, Charuchinda, C, Balali-Mood, M, Boye. GL, Chan, TY, Brocklesby, NC and Lee MR (1990) Ethnic difference in the renal dopamine response to an oral salt
load. J. Human Hypertension. 4: 91-93 (Makarananda et al. 1998)*
49) Lee, MR, Critchley, JA, Gordon, CJ, Makarananda, K, SRIWATANAKUL, K, Balali-Moods, M and Boye, GL (1990) Ethnic differences in the renal sodium-dopamine relationship : a possible explanation for regional variation in the prevalence of hypertension? Am. J. Hypertension. 3: 100S-103S
50) Ruangkanchanasetr, S, SRIWATANAKUL, K, Luptawan, S and Prapat-tong, S (1991) Epidemiology and risk factors of injury in Thai children. Southeast Asian J. Tropical Medicine and Public Health. 22:127-32
51) Prescott, LF, Yoovathaworn, K, Makarananda, K, Saivises, R and SRIWATANAKUL, K (1993) Imparied absorption of paracetamol in vegetarians. Br. J. Clin. Pharmac. 36: 237-240 (Prescott et al.1993)*
52) SRIWATANAKUL, K and Sriwatanakul, K (1995) The efficacy and side effects of antiflatulents in the treatment of functional dyspepsia. Naresuan University J. 3: 1-4
53) SRIWATANAKUL, K, Patimaarak, S, Yoovathaworn, K and Sriwatanakul, KM (1998) P1F140. Adverse drug reaction (ADR) monitoring of aminoglycosides (AG) in rajavithi hospital
54) Makarananda, K, Pengpan, U, Srisakulthong, M, Yoovathaworn, K and SRIWATANAKUL, K (1998) Monitoring of aflatoxin exposure by biomarkers. J. Toxicol. Sciences 23: (Suppl 11) 155-159
55) Muangman, V, Thithapanda, A Yoovathaworn, K, Supavilai, P, Arunnopparat, W and SRIWATANAKUL, K (1998) A study on diuretic effects of Pluchea indica in man. Thai. J. Urol. 19:116-128
56) Jeenapongsa, R, Yoovathaworn, K, Sriwatanakul, KM, Pongprayoon, U and SRIWATANAKUL, K (2003) Anti-inflammatory activity of (E)-1-(3,4-dimethoxyphenyl) butadiene from Zingiber cassumunar Roxb. J. Ethnopharmacology. 87: 143-8
57) Peamkrasatam, S, Kiyotani, K, Fujieda, M, Yamazaki, H, Kamataki, T, Yoovathaworn, K and SRIWATANAKUL, K (2007) In vivo Evaluation of Coumarin and Nicotine as Probe Drugs to Predict the Metabolic Capacity of CYP2A6 Due to Genetic Polymorphism in Thais. Drug Metabolism and Pharmacokinetics. 21: 475-84
58) Rattanakhot, N, Toojinda, P, Temjarean, P, Aramphongphan, A and SRIWATANAKUL, K (2007) P13 Toxicological Evaluation of Commercial Thai Herbal Preparations.
Activities Related to Stem Cell Technology
1. Founder of The Thai Society of Cellular Therapy (TSCT)
2. Invited lecturer in the Speaker Bureau of A4M China and ACAM, USA
3. Member of The International Society for Cellular Therapy (ISCT)
4. Medical Director of Acquest Laboratory
5. President and CEO of Vitastem Co., Ltd engaging in PRP, CAL and Immunotherapy
6. Founder of Stem Cell for Life Co., Ltd, the pioneer cord blood bank in Thailand
7. President and Founder of Bio Eden Asia Co., Ltd. (Tooth cell banking)
8. President and Founder of Biosomatic Co., Ltd, ADSC bank
9. Medical consultant of Thai Health Baby Biotech Co., Ltd. (Cord blood and cord MSC banking)
10. Invited Speaker on application of stem cell therapy in medicine and dentistry, several national and international meeting
11. Engaging in several research and development projects related to application of mesenchymal stem cell in anti-aging and regenerative medicine
12. Invited Speakers in several international conferences on Stem Cells Technology such as
- Topic: “Cryopreservation and stem cell banking” given to ACAM Stem Cell Workshop
Spring 2015 Conference, San Diego, California. - Topic: “Applying the principle of stem cell biotechnology to regenerative medicine” given to the 2nd IAIM Seminar, 30th May 2015, Bangkok, Thailand.
- Topic: “Update on stem cell therapy for Asean Physicians” given to the 3rd IAIM Seminar, 27th June 2015, Bangkok, Thailand.
- Topic: “Integrative Medical Therapies” given to the 4th IAIM Seminar, 14th August 2017, Bangkok, Thailand.
- Topic: “New episodes of immortality” given to Mae Fah Lung University: School of Anti-Aging and Regenerative Medicine Conference, 9th – 10th September 2017, Bangkok, Thailand.
- Topic: “AUTISM: Learning Difficulties and Development Disabilities” given to the 5th IAIM Seminar, 29th – 31st March 2018, Chiang Mai, Thailand.
- Topic: “Applications of stem cell technology in anti-aging medicine” given to the International Conference on Stem Cells and Regenerative Medicine, 18th – 19th June 2018, Osaka, Japan. Dr.Kampon Sriwatanakul M.D., Ph.D. Page 9
- Topic: “Hepatocytes produced from human tooth pulp into swine with cirrhosis: two transplantations with time interval” given to the 13th International Conference on Tissue
Engineering & Regenerative Medicine, 12th – 13th July 2018, Paris, France. - Topic: “Innovative products derived from probiotics and nanotechnology” given to the Euro Congress on Biotechnology, 26th – 27th November 2018, Madrid, Spain.
Nutraceuticals & Herbal Medicine Research Interest
1. Curcuma Longa for gastrointestinal disease
2. Zingiber Cassumunar for Pain and Inflammation
3. Alphanizomenon Flos Aquae for supporting the release of stem cells
4. Medicinal Mushrooms for enhancing immunity
5. Pueraria Mirifica for Female Menopause
6. Kaempferia Parviflora for Men with Andropause
7. Blue-green algae (Aphanizomenon Flos Aquae) for stem cell release
- Houttuynia cordata extract for Covid-19 prevention and treatments
- Oxyresveratrol and biological immortality
- Curcuminoid and oxidative stress